The national burden of E-code-identified adverse drug events among hospitalized children using a national discharge database

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 8, 2011, Pages 866-878

  Tundia, Namita L ^a   Heaton, Pamela C ^a   Kelton, Christina M L ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Accidental poisoning; Adverse drug events; Adverse effects; E codes; Kids' Inpatient Database (KID); National burden of illness

Indexed keywords

ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; ANTIRHEUMATIC AGENT; BENZODIAZEPINE; CENTRAL STIMULANT AGENT; CEPHALOSPORIN; CORTICOSTEROID; HYDANTOIN DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PENICILLIN DERIVATIVE; SALICYLIC ACID;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ARTICLE; CHILD; CONTACT DERMATITIS; CONTROLLED STUDY; DATA BASE; DERMATITIS; E CODE; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HOSPITALIZED CHILD; HUMAN; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; INTOXICATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHOOL CHILD; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DATABASES, FACTUAL; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; MALE; PATIENT DISCHARGE; PHARMACEUTICAL PREPARATIONS; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 79960701538     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2150     Document Type: Article

References (20)

1. Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ. Reported adverse drug events in infants and children under 2years of age. Pediatrics 2002; 110(5): e53.
2. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285(16): 2114-2120.
3. Rodriguez W, Roberts R, Murphy D. Adverse drug events in children: the US Food and Drug Administration perspective. Current Therap Res 2001; 62(10): 711-723.
4. Woods D, Thomas E, Holl J, Altman S, Brennan T. Adverse events and preventable adverse events in children. Pediatrics 2005; 115: 155-160.
5. Elixhauser A, Owens P, for AHRQ. Adverse drug events in U.S. hospitals, 2004. HCUP Statistical Brief #29, April 2007, Agency for Healthcare Research and Quality, Rockville, MD. [15 September 2008].
6. United States General Accounting Office. Adverse drug events: the magnitude of health risk is uncertain because of limited incidence data. GAO/HEHS-00-21, Washington DC, Jan 2000. [25 October 2008].
7. Bates DW, Spell N, Cullen DJ, et al, for the ADE Prevention Study Group. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277(4): 307-311.
8. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277(4): 301-306.
9. Zhan C, Miller M. Excess length of stay, charges and mortality attributable to medical injuries during hospitalization. JAMA 2003; 290(14): 1868-1874.
10. Wynn B, Beckett M, Hilborne L, Scott M, Bahney B. for Centers for Medicare and Medicaid Services. Evaluation of severity adjusted DRG system. RAND Health, July 2007. [21 October 2008].
11. Healthcare Cost and Utilization Project. Introduction to the HCUP KIDS' Inpatient Database (KID). 2006. [13 September 2008].
12. Bureau of Labor and Statistics. Consumer Price Index-all urban consumers. CPI for hospital inpatient services. 2010. [6 June 2010].
13. Dormann H, Criegee-Rieck M, Neubart A, et al. Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma. Drug Saf 2003; 26(5): 353-362.
14. Daukes SE, Simpson CR, Helmes PJ, Taylor MW, McLay JS. Burden of corticosteroids in children with asthma in primary care: retrospective observational study. BMJ 2002; 324(7350): 1374.
15. Mangrella M, Motola G, Russo F, et al. Intensive hospital monitoring of adverse reactions to benzodiazepines and neuroleptic agent (in Italian). Minerva Med 1998; 89(7-8): 293-300.
16. Holdsworth MT, Fichtl RT, Behta M, et al. Incidence and impact of adverse drug events in pediatric inpatients. Arch Pediatr Adolesc Med 2003; 157(1): 60-65.
17. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29(5): 385-396.
18. Leonard CE, Haynes K, Localio AR, et al. Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events. J Clin Epidemiol 2008; 61: 561-571.
19. Coben JH, Steiner CA, Barrett M, Merrill CT, Adamson D. Completeness of cause of injury coding in healthcare administrative databases in the United States, 2001. Inj Prev 2006; 12(3): 199-201.
20. Barrett M, Steiner C. Addendum to Healthcare Cost and Utilization Project (HCUP) E code evaluation report. HCUP Methods Series Report #2004-06, U.S. Agency for Healthcare Research and Quality, ONLINE 10 November 2010. [8 February 2011].